VAUGHAN, ONTARIO--(Marketwire - March 13, 2008) - Prism Medical Ltd. (“Prism”) (TSX VENTURE: PM) announced today that it granted options to acquire 120,000 common shares at an option price of $3.61 subject to the terms and conditions of a Stock Option Plan restated and amended by Prism on May 27, 2005. The options have a term of three years. These options included 50,000 options granted to Andrew McIntyre, 35,000 options granted to Charley Wallace and 35,000 granted to Miles Atkinson, all senior officers of Prism.
